OOIR: Observatory of International Research

Papers

(The median citation count of Best Practice & Research in Clinical Rheumatology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy	131
Exercise and inflammation	100
Clinical manifestations and treatment of antisynthetase syndrome	56
Role of diet in hyperuricemia and gout	54
Diffuse idiopathic skeletal hyperostosis: Etiology and clinical relevance	50
The epidemiology of psoriatic arthritis: A literature review	42
Global health policy in the 21st century: Challenges and opportunities to arrest the global disability burden from musculoskeletal health conditions	41
Cardiac involvement in systemic sclerosis: Getting to the heart of the matter	34
The interplay between neutrophils, complement, and microthrombi in COVID-19	34
Musculoskeletal health in the workplace	34
Systemic autoinflammatory diseases: Clinical state of the art	33
Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes	27
Hypertrophic osteoarthropathy	26
Implementing models of care for musculoskeletal conditions in health systems to support value-based care	25
Innovations to improve access to musculoskeletal care	25
Managing patients using telerheumatology: Lessons from a pandemic	25
Exercise therapy in patients with idiopathic inflammatory myopathies and systemic lupus erythematosus – A systematic literature review	25
Risk assessment tools for osteoporosis and fractures in 2022	24
Current status of imaging of Sjogren's syndrome	23
Allopurinol hypersensitivity: Pathogenesis and prevention	23
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc	22
Primary hyperparathyroidism	21
Symptomatic joint hypermobility	21
Erdheim–Chester disease	20
Clinical features of psoriatic arthritis	20

Nonpharmacological and nonsurgical approaches in OA	19
Multiple hereditary exostoses and enchondromatosis	18
The impact of lifestyle behaviours, physical activity and smoking on morbidity and mortality in patients with rheumatoid arthritis	18
Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)	18
Modifiable risk factors for bone health & fragility fractures	17
Current status of MR imaging of juvenile idiopathic arthritis	17
Contemporary imaging of rheumatoid arthritis: Clinical role of ultrasound and MRI	16
Improving musculoskeletal health for children and young people – A ‘call to action’	16
Managing work participation for people with rheumatic and musculoskeletal diseases	15
Osteoporosis in 2022: Care gaps to screening and personalised medicine	15
Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions	15
CNS vasculopathies: Challenging mimickers of primary angiitis of the central nervous system	15
Imaging in the diagnosis and management of peripheral psoriatic arthritis	14
Opportunistic tropical infections in immunosuppressed patients	14
Imaging in large-vessel vasculitis	13
Ultrasound imaging in paediatric rheumatology	13
Treating-to-target in rheumatology: Theory and practice	12
Risk factors for osteoporosis and fractures in rheumatoid arthritis	12
Muscle imaging in myositis: MRI, US, and PET	12
Treatment advances in gout	12
Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implications	12
Pathogenesis of psoriatic arthritis	12
Urate transport in health and disease	11
A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis	11
Pathogenesis of calcium pyrophosphate deposition disease	11
The microbiome and systemic sclerosis: A review of current evidence	11
Fatigue in inflammatory arthritis	11
Botulinum toxin in the management of primary and secondary Raynaud's phenomenon	11
Imaging in the diagnosis and management of axial spondyloarthritis in children	10
Unmet needs in psoriatic arthritis	10
Diagnosis, classification, and assessment in psoriatic arthritis	9
The global burden of fragility fractures – what are the differences, and where are the gaps	9
Change of the microvascularization in systemic sclerosis, a matter of air	9
The role of calcium crystals and their effect on osteoarthritis pathogenesis	9
High-quality RMD rehabilitation and telehealth: Evidence and clinical practice	9
Uncommon compressive neuropathies of upper limbs	9
Arboviruses related with chronic musculoskeletal symptoms	9
Employment outcomes in systemic sclerosis	9
Treatment of rheumatic adverse events of cancer immunotherapy	8
Pre-RA: Can early diagnosis lead to prevention?	8
Clinical insights into Charcot foot	8
The protective effect of rheumatic disease agents in COVID-19	8
Horizon scan: State-of-the-art therapeutics for psoriatic arthritis	8
Risk for osteoporosis and fracture with glucocorticoids	8
Lower extremity entrapment neuropathies	8
Precision medicine in rheumatoid arthritis	8
The genetic basis of urate control and gout: Insights into molecular pathogenesis from follow-up study of genome-wide association study loci	8
Osteoporosis in children and young adults	8
Imaging in psoriatic arthritis: Status and recent advances	7
Calcium pyrophosphate deposition (CPPD) disease – Treatment options	7

The evaluation and treatment of Paget's disease of bone	7
Microbes, helminths, and rheumatic diseases	7
Infectious mimics of rheumatoid arthritis	7
Management of interstitial lung disease (ILD) in myositis syndromes: A practical guide for clinicians	7
Current treatments and recommendations for Psoriatic Arthritis	7
Osteoarthritis today: Lost in translation?	7
Management of Takayasu arteritis	7
Update of imaging in the diagnosis and management of axial spondyloarthritis	7
Cardiovascular disease and depression in psoriatic arthritis: Multidimensional comorbidities requiring multidisciplinary management	7
Review: Outcome measures in calcium pyrophosphate deposition	6
Possible future avenues for myositis therapeutics: DM, IMNM and IBM	6
Calcinosis in dermatomyositis: Origins and possible therapeutic avenues	6
Review for best practice in clinical rheumatology juvenile systemic sclerosis – Updates and practice points	6
Rheumatoid arthritis: Evolving recognition of a common disease	6
Prevention and adherence in Rheumatic and Musculoskeletal disease	6
Imaging of crystalline arthropathy in 2020	5
Is it really myositis? Mimics and pitfalls	5
Autoantibodies: Pathogenic or epiphenomenon	5
Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain?	5
The burden of osteoarthritis: Is it a rising problem?	5
Computed tomography in rheumatology – From DECT to high-resolution peripheral quantitative CT	5
Clinical and molecular significance of genetic loci associated with psoriatic arthritis	5
Imaging of OA – From disease modification to clinical utility	5
Cancer and myositis: Who, when, and how to screen	5
What do people need?	5
Systemic lupus erythematosus	4
Antifibrotics in systemic sclerosis	4
Advances in delivery of health care for MSK conditions	4
Impaired bone health as a co-morbidity of epilepsy	4
Prediction of treatment response: Personalized medicine in the management of rheumatoid arthritis	4
Treatment overview of axial spondyloarthritis in 2023	4
Nailfold capillaroscopy	4
The racial/ethnic and sociocultural aspects of the pandemic in rheumatology	3
Novel therapies and innovation for systemic sclerosis skin ulceration	3
Implications of a diagnosis of rheumatoid arthritis in resource-poor countries	3
Immunologic adverse events from immune checkpoint therapy	3
Classification and epidemiology of vasculitis: Emerging concepts	3
Male osteoporosis-what are the causes, diagnostic challenges, and management	3
COVID-19 pandemic management and the rheumatology patient	3
Pain in osteoarthritis from a symptom to a disease	3
Diabetes and osteoporosis – Treating two entities: A challenge or cause for concern?	3
Lacrimal and salivary gland ultrasound - how and when to use in patients with primary Sjögren's syndrome	3
Laboratory evaluation of SARS-CoV-2 in the COVID-19 pandemic	3
Inclusion body myositis: The interplay between ageing, muscle degeneration and autoimmunity	3
Assessment of disease activity and damage in SLE: Are we there yet?	2
Clinical advances – from bench to bedside	2
Seeing is believing: Smart use of musculoskeletal ultrasound in rheumatology practice	2
Challenges in the diagnosis of axial spondyloarthritis	2
Synovial fluid analysis: Relevance for daily clinical practice	2
The challenge of gout flare measurement	2
Relapsing polychondritis: Best Practice & Clinical Rheumatology	2
Biomarkers for osteoarthritis: Current status and future prospects	2
Muscle biopsy in myositis: What the rheumatologist needs to know	2
Vascular ultrasound in rheumatology practice	2
Clinical aspects and outcomes in osteoarthritis	2
When are patients with osteoarthritis referred for surgery?	2
Psoriatic Arthritis: Current status	2
Functional capacity, sarcopenia, and bone health	2
Enhancing patient research partner engagement: Research in psoriatic arthritis	2
Osteoporosis evaluation and treatment recommendations in rheumatoid arthritis	2
Best practices for ultrasound-guided synovial biopsy in the United States	2
Cardiovascular risk in vasculitis	2